BofA analyst Graham Parry lowered the firm’s price target on GSK to 1,390 GBp from 1,450 GBp and keeps an Underperform rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GSK:
- Compugen wins on PVRIG European patent opposition pursued by GSK, third party
- Buy/Sell: Wall Street’s top 10 stock calls this week
- GSK initiated with a Reduce at HSBC
- Haleon to cut thousands of jobs globally, Guardian reports
- GSK begins shipping flu vaccines to US healthcare providers ahead of flu season